Prof John Deanfield, the director of the National Institute for Cardiovascular Outcomes Research and the lead author of the study, said the findings showed that the medication should be routinely prescribed to treat cardiovascular illnesses, and that millions of people across the UK could be taking the medication in the next few years
However, persistent or distressing changes should be discussed with a healthcare provider
Semaglutide is a synthetic analogue of the glucagon-like peptide-1 (GLP-1) hormone
For this group, cost-effectiveness outcomes appear highly sensitive to both product pricing and the specific WTP thresholds applied across national contexts, with positive results in the United States and less favorable outcomes in jurisdictions with more stringent thresholds or higher price assumptions
The Injection: Insert the needle into the skin
Pricing, policy terms, and program details are subject to change